Company profile: Guava Technologies
1.1 - Company Overview
Company description
- Provider of biotechnology and medical devices, including unique flow cytometry and benchtop cell analysis systems. Offers HIV/AIDS monitoring, viacount cell counting and viability assays, antibody quantification, apoptosis assay suite, cell cycle, cytotoxicity, and cell proliferation assays.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Guava Technologies
Atera Labs
HQ: Luxembourg
Website
- Description: Provider of advanced human tissue models and tissue engineering solutions, specializing in R&D, validation, manufacturing and commercialization to deliver reliable, cost-effective, high-quality test methods for product evaluation, gradually reducing and replacing animal experimentation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atera Labs company profile →
Expedeon
HQ: United States
Website
- Description: Provider of cutting-edge innovative reagents and services for life sciences and diagnostics, with applications across workflows including protein electrophoresis, liquid biopsy, whole genome amplification, antibody- and protein-labeling, and immunoassay development; offering off-the-shelf products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Expedeon company profile →
NanoMR
HQ: United States
Website
- Description: Provider of blood diagnostic devices and an immunomagnetic capture system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower, enabling simultaneous targeting of multiple cell types, including bacteria and fungi from bloodstream infections, as well as specific cells such as circulating tumor and fetal cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoMR company profile →
Clean Cells
HQ: France
Website
- Description: Provider of biosafety and quality control testing for biopharmaceuticals, including vaccines, monoclonal antibodies, and cell and gene therapies; GMP manufacturing of cell and virus banks and Master/Working Cell Banks; secure GMP and non-GMP storage; development of cytotoxicity potency assays; purity and identity testing; and production of experimental drugs such as cell therapy products and therapeutic phages.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clean Cells company profile →
Numerate
HQ: United States
Website
- Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Numerate company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Guava Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Guava Technologies
2.2 - Growth funds investing in similar companies to Guava Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Guava Technologies
4.2 - Public trading comparable groups for Guava Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →